These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23951194)

  • 1. Mapping, bayesian geostatistical analysis and spatial prediction of lymphatic filariasis prevalence in Africa.
    Slater H; Michael E
    PLoS One; 2013; 8(8):e71574. PubMed ID: 23951194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling.
    Slater H; Michael E
    PLoS One; 2012; 7(2):e32202. PubMed ID: 22359670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.
    Moraga P; Cano J; Baggaley RF; Gyapong JO; Njenga SM; Nikolay B; Davies E; Rebollo MP; Pullan RL; Bockarie MJ; Hollingsworth TD; Gambhir M; Brooker SJ
    Parasit Vectors; 2015 Oct; 8():560. PubMed ID: 26496983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
    Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
    BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
    Michael E; Singh BK
    BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa.
    Touloupou P; Retkute R; Hollingsworth TD; Spencer SEF
    Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100391. PubMed ID: 35691660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the baseline prevalence of lymphatic filariasis across Nigeria.
    Eneanya OA; Fronterre C; Anagbogu I; Okoronkwo C; Garske T; Cano J; Donnelly CA
    Parasit Vectors; 2019 Sep; 12(1):440. PubMed ID: 31522689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
    Singh BK; Michael E
    Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The national distribution of lymphatic filariasis cases in Malawi using patient mapping and geostatistical modelling.
    Barrett C; Chiphwanya J; Mkwanda S; Matipula DE; Ndhlovu P; Chaponda L; Turner JD; Giorgi E; Betts H; Martindale S; Taylor MJ; Read JM; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012056. PubMed ID: 38527064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping and estimating the population at risk from lymphatic filariasis in Africa.
    Lindsay SW; Thomas CJ
    Trans R Soc Trop Med Hyg; 2000; 94(1):37-45. PubMed ID: 10748895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial variation in lymphatic filariasis risk factors of hotspot zones in Ghana.
    Kwarteng EVS; Andam-Akorful SA; Kwarteng A; Asare DB; Quaye-Ballard JA; Osei FB; Duker AA
    BMC Public Health; 2021 Jan; 21(1):230. PubMed ID: 33509140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global distribution and transmission limits of lymphatic filariasis: past and present.
    Cano J; Rebollo MP; Golding N; Pullan RL; Crellen T; Soler A; Kelly-Hope LA; Lindsay SW; Hay SI; Bockarie MJ; Brooker SJ
    Parasit Vectors; 2014 Oct; 7():466. PubMed ID: 25303991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian geostatistical modelling of malaria and lymphatic filariasis infections in Uganda: predictors of risk and geographical patterns of co-endemicity.
    Stensgaard AS; Vounatsou P; Onapa AW; Simonsen PE; Pedersen EM; Rahbek C; Kristensen TK
    Malar J; 2011 Oct; 10():298. PubMed ID: 21989409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatially explicit Schistosoma infection risk in eastern Africa using Bayesian geostatistical modelling.
    Schur N; Hürlimann E; Stensgaard AS; Chimfwembe K; Mushinge G; Simoonga C; Kabatereine NB; Kristensen TK; Utzinger J; Vounatsou P
    Acta Trop; 2013 Nov; 128(2):365-77. PubMed ID: 22019933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.
    Singh BK; Bockarie MJ; Gambhir M; Siba PM; Tisch DJ; Kazura J; Michael E
    PLoS One; 2013; 8(6):e67004. PubMed ID: 23826185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spatial distribution of Schistosoma mansoni infection in four regions of western Côte d'Ivoire.
    Assaré RK; Lai YS; Yapi A; Tian-Bi YN; Ouattara M; Yao PK; Knopp S; Vounatsou P; Utzinger J; N'Goran EK
    Geospat Health; 2015 Jun; 10(1):345. PubMed ID: 26054523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
    Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
    BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental suitability for lymphatic filariasis in Nigeria.
    Eneanya OA; Cano J; Dorigatti I; Anagbogu I; Okoronkwo C; Garske T; Donnelly CA
    Parasit Vectors; 2018 Sep; 11(1):513. PubMed ID: 30223860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecological Drivers of Mansonella perstans Infection in Uganda and Patterns of Co-endemicity with Lymphatic Filariasis and Malaria.
    Stensgaard AS; Vounatsou P; Onapa AW; Utzinger J; Pedersen EM; Kristensen TK; Simonsen PE
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004319. PubMed ID: 26793972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.